Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3697064010 | Natalizumab 300 mg/15 mL solution for injection vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3697065011 | Product containing precisely natalizumab 300 milligram/15 milliliter conventional release solution for injection vial (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4158951000052112 | natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Has precise active ingredient | Natalizumab (substance) | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | har nämnarvärde som visar styrka | 15 | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Has manufactured dose form | Solution for injection | false | Inferred relationship | Some | ||
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | har täljarvärde för koncentrationsstyrka | 20 | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | har täljarvärde som visar styrka | 300 | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Is a | Product containing natalizumab (medicinal product) | false | Inferred relationship | Some | ||
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Has presentation strength denominator unit (attribute) | mL | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | har nämnarvärde som visar koncentrationsstyrka | ett | false | Inferred relationship | Some | 1 | |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska | Has basis of strength substance (attribute) | Natalizumab (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR